Publication | Open Access

Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior—Outcomes of a randomized trial

Illicit BuprenorphineOpioid EpidemicSubstance AbuseSubstance UseHarm ReductionHealth PolicyAddictionDrug PolicyAddiction MedicineHiv Risk Behavior—outcomesPharmacotherapyRandomized TrialDrug TreatmentMedicineSubstance Use DisordersOpioid Use DisorderHealth Sciences